Search research articles
Contact Us
Filters
Showing results (141-150 of 182) with videos related to
Page
of 19
Sort By:
The European Respiratory Journal
|
April 4, 2024
Benralizumab in severe eosinophilic asthma by previous biologic use and key clinical subgroups: real-world XALOC-1 programme
David J Jackson, Girolamo Pelaia, Benjamin Emmanuel, et al.
Annals of the Rheumatic Diseases
|
August 8, 2025
Two-year efficacy and safety of anti-interleukin-5/receptor therapy for eosinophilic granulomatosis with polyangiitis
Peter A Merkel, Parameswaran K Nair, Nader Khalidi, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
August 3, 2025
Effects of obesity on response to asthma biologic treatment: Longitudinal data from the United Kingdom Severe Asthma Registry
Sherif Gonem, Charlene Redmond, John Busby, et al.
Nature Communications
|
April 22, 2023
Rhinovirus-induced epithelial RIG-I inflammasome suppresses antiviral immunity and promotes inflammation in asthma and COVID-19
Urszula Radzikowska, Andrzej Eljaszewicz, Ge Tan, et al.
Nature Communications
|
June 13, 2023
Author Correction: Rhinovirus-induced epithelial RIG-I inflammasome suppresses antiviral immunity and promotes inflammation in asthma and COVID-19
Urszula Radzikowska, Andrzej Eljaszewicz, Ge Tan, et al.
American Journal of Respiratory Cell and Molecular Biology
|
December 2, 2020
Rhinovirus-induced CCL17 and CCL22 in Asthma Exacerbations and Differential Regulation by STAT6
Teresa C Williams, David J Jackson, Steven Maltby, et al.
American Journal of Respiratory and Critical Care Medicine
|
September 1, 2021
Pulmonary Innate Lymphoid Cell Responses during Rhinovirus-induced Asthma Exacerbations <i>In Vivo</i>: A Clinical Trial
Jaideep Dhariwal, Aoife Cameron, Ernie Wong, et al.
Ebiomedicine
|
April 5, 2017
A Comprehensive Evaluation of Nasal and Bronchial Cytokines and Chemokines Following Experimental Rhinovirus Infection in Allergic Asthma: Increased Interferons (IFN-γ and IFN-λ) and Type 2 Inflammation (IL-5 and IL-13)
Trevor T Hansel, Tanushree Tunstall, Maria-Belen Trujillo-Torralbo, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
December 14, 2020
Potential Severe Asthma Hidden in UK Primary Care
Dermot Ryan, Heath Heatley, Liam G Heaney, et al.
Chest
|
February 1, 2026
Sex does not modify prediction of asthma attacks by clinical risk factors and Type-2 biomarkers
Sebastian Riemann, Fleur L Meulmeester, Samuel Mailhot-Larouche, et al.
Page
of 19
Search research articles
Search
Showing results (141-150 of 182) with videos related to
Sort By:
Page
of 19
The European Respiratory Journal
|
April 4, 2024
Benralizumab in severe eosinophilic asthma by previous biologic use and key clinical subgroups: real-world XALOC-1 programme
David J Jackson, Girolamo Pelaia, Benjamin Emmanuel, et al.
Annals of the Rheumatic Diseases
|
August 8, 2025
Two-year efficacy and safety of anti-interleukin-5/receptor therapy for eosinophilic granulomatosis with polyangiitis
Peter A Merkel, Parameswaran K Nair, Nader Khalidi, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
August 3, 2025
Effects of obesity on response to asthma biologic treatment: Longitudinal data from the United Kingdom Severe Asthma Registry
Sherif Gonem, Charlene Redmond, John Busby, et al.
Nature Communications
|
April 22, 2023
Rhinovirus-induced epithelial RIG-I inflammasome suppresses antiviral immunity and promotes inflammation in asthma and COVID-19
Urszula Radzikowska, Andrzej Eljaszewicz, Ge Tan, et al.
Nature Communications
|
June 13, 2023
Author Correction: Rhinovirus-induced epithelial RIG-I inflammasome suppresses antiviral immunity and promotes inflammation in asthma and COVID-19
Urszula Radzikowska, Andrzej Eljaszewicz, Ge Tan, et al.
American Journal of Respiratory Cell and Molecular Biology
|
December 2, 2020
Rhinovirus-induced CCL17 and CCL22 in Asthma Exacerbations and Differential Regulation by STAT6
Teresa C Williams, David J Jackson, Steven Maltby, et al.
American Journal of Respiratory and Critical Care Medicine
|
September 1, 2021
Pulmonary Innate Lymphoid Cell Responses during Rhinovirus-induced Asthma Exacerbations <i>In Vivo</i>: A Clinical Trial
Jaideep Dhariwal, Aoife Cameron, Ernie Wong, et al.
Ebiomedicine
|
April 5, 2017
A Comprehensive Evaluation of Nasal and Bronchial Cytokines and Chemokines Following Experimental Rhinovirus Infection in Allergic Asthma: Increased Interferons (IFN-γ and IFN-λ) and Type 2 Inflammation (IL-5 and IL-13)
Trevor T Hansel, Tanushree Tunstall, Maria-Belen Trujillo-Torralbo, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
December 14, 2020
Potential Severe Asthma Hidden in UK Primary Care
Dermot Ryan, Heath Heatley, Liam G Heaney, et al.
Chest
|
February 1, 2026
Sex does not modify prediction of asthma attacks by clinical risk factors and Type-2 biomarkers
Sebastian Riemann, Fleur L Meulmeester, Samuel Mailhot-Larouche, et al.
Page
of 19